Latest news with #Manual
The Sun
a day ago
- Health
- The Sun
The TRUTH about Ozemd**k – the bizarre weight loss jab side-effect that's ‘adding inches' to manhood size
OZEMPIC-PENIS sounds like a sexually transmitted disease you really wouldn't want to catch. But it's actually a term that has cropped up online, largely amongst men on Reddit, who are saying they've noticed a change to their penis size as a side-effect of weight loss injections. One anonymous user wrote: 'I recently measured myself down there and noticed I gained about one inch.' Another asked: 'Increased size, anyone else notice?' Weight loss drugs were first developed to treat type 2 diabetes, and Ozempic is still prescribed for just that. Wegovy and Mounjaro, which are available on the NHS, and Saxenda, meanwhile are licensed for weight management, but only obese Brits (a BMI over 30), or those that are overweight (a BMI of 27) with a related comorbidity like high blood pressure or high cholesterol, are eligible for them. They work by mimicking naturally occurring hormones, like GLP-1, that make you feel full, slow digestion and regulate appetite, leading to sometimes drastic fat loss. The health benefits can be huge considering obesity can cause cancer, type 2 diabetes, heart disease, cancer and more. But is it too good to be true that the drugs can add inches to your penis as well? We asked GP and men's health and erectile dysfunction expert Dr Jeff Foster, Medical Director of Manual, to explain all… Can taking weight loss drugs really make your penis bigger? 4 THE short answer is no, but the drugs can certainly make your penis LOOK bigger. 'It's true,' says Dr Foster. 'You naturally have a small fat pad just above the base of the top of your penis. What is Erectile Dysfunction? 'As you develop abdominal fat - and men in particular will develop abdominal fat compared to women, who put it on their bum and thighs more - you can find this small, little fat pad starts to become fuller. 'It appears, therefore, that everything has shrunk. 'It's as if your penis has gone inside, but all that's really happening is the surrounding tissue to your penis has become more protruded - the true penis size hasn't changed. 'And in fact, about 70 per cent of your penis is external, there's another 30 per cent inside that you just never see.' Pre-Ozempic, some men found this illusion so upsetting that they'd be referred for liposuction to have the fat pad reduced. 'The removal of this fat pad just above the penis does make it look bigger, but the problem is, it's not actually any bigger, it's just the appearance of the outward area,' says Dr Foster. Losing some of that fat pad as a side-effect of weight loss drugs can have the same effect though - and doesn't involve a surgical procedure. 'It's a win, isn't it?' says Dr Foster. 'You're going to be healthier, and you might end up looking like you've got a bigger penis. 'I mean, no men are ever going to go, 'Ah, I'm really worried my penis is too big'.' Do fat jabs help improve erections too? 4 'DEFINITELY,' says Dr Foster 'Fat increases oestrogen levels in men, and it also reduces testosterone and increases insulin resistance. 'All of those three together will have a really negative impact on your testosterone production. 'And if you haven't got testosterone, or not as much of it, you don't get a libido, you don't get erections. 'So it's really simple: by reducing your body fat, your erections get better, your sex drive goes up and you feel more manly.' Does that mean weight loss meds could eventually be prescribed for ED? 'IT could be one of your tools as part of an overall arsenal of treating erectile dysfunction (ED), but you wouldn't use it as a primary treatment,' says Dr Foster, who says that crucially you need to find the root cause of the problem. 'The biggest cause of erectile dysfunction in men is still heart disease. 'If you've got narrowing of the arteries you can't get a decent erection. 'Your penile artery is almost identical in calibre and design to your coronary artery. 'That's how they discovered Viagra - it was designed for blood pressure in your heart originally, and they found it worked really well down below.' He adds: 'This is why we say to men, if you have got erectile dysfunction, find out why. 'The worst thing you can do is just buy some over the counter tablet without finding out why [it's happening]. 'We say that on average, if you have an arterial cause for erectile dysfunction, you have about a three-year window before something bad happens to your heart, like a heart attack - so really understand the cause.' This is when weight loss drugs could make a difference, by supporting overall heart health, and therefore, erection health. 'If we think there's a cardiovascular cause, then using something like Ozempic or Mounjaro could be amazing, because not only do you fix your erection, but you actually fix the underlying process that's causing the whole thing,' says Dr Foster. 'It improves your heart and your penis.' Are there any potential penile risks? 4 'I'VE heard the rumour that allegedly GLP-1 drugs may reduce penis size or have adverse effects on male health in general,' says Dr Foster. 'The theory behind it is whether testosterone or male wellbeing is affected by GLP-1s.' He explains: 'GLP-1s work by improving satiety, so you eat less. 'By doing that, you reduce body fat, but the other part of that, which we're now seeing evidence of, is that if you're not careful, you also start to reduce muscle mass. 'That's the big worry, because on one hand, yes, you want to get rid of excess fat, but you don't want to reduce your muscle because that's not healthy for anyone.' Loss of muscle can lead to falls, lack of mobility, increased fractures, and in older age, even premature death. '[People] think that sarcopenia-effect (muscle loss) is because of lowered testosterone, but it's probably not a direct effect of [GLP-1s],' he explains. Muscle loss is a problem that should be managed though, whether you're worried about how your penis looks or not. 'If you are going to be taking a weight-loss drug and want to maintain your masculinity, then you have to make sure you eat enough protein and do weight bearing exercise,' says Dr Foster firmly. 'You must do both, and that will help your erections, because we are starting to see the effects of weight loss drugs causing loss of muscle and that's having massively negative impacts on male health. 'To maintain your testosterone, to maintain your erection, make sure you do some decent exercise, and make sure you eat enough protein, even if you don't feel like it, because otherwise you're going to lose more important things [than fat alone], like sexual function and muscle.'
Business Wire
5 days ago
- Business
- Business Wire
Superior Industries International, Inc. Receives NYSE Notice
SOUTHFIELD, Mich.--(BUSINESS WIRE)-- Superior Industries International, Inc. ('Superior' or the 'Company') (NYSE:SUP), one of the world's leading aluminum wheel suppliers, today announced that on June 17, 2025, it received a written notice from the New York Stock Exchange (the 'NYSE') that the Company no longer satisfies the continued listing compliance standards set forth under Section 802.01C of the NYSE Listed Company Manual (the 'Manual') because the average closing price of the Company's common stock, par value $0.01 per share (the 'Common Stock') was less than $1.00 per share over a consecutive 30-trading day period (the 'Notice'). Pursuant to Section 802.01C of the Manual, the Company has a period of six months following receipt of the Notice to regain compliance with the minimum share price requirement, with the possibility of extension at the discretion of the NYSE. In order to regain compliance, on the last trading day in any calendar month during the cure period, the Common Stock must have: (i) a closing price of at least $1.00 per share; and (ii) an average closing price of at least $1.00 per share over the 30 trading-day period ending on the last trading day of such month. Pursuant to NYSE rules, the Common Stock will continue to be listed and traded on NYSE during the cure periods outlined above, subject to the Company's compliance with other NYSE continued listing requirements. The current noncompliance with the standards described above does not affect the Company's ongoing business operations or its reporting requirements with the Securities and Exchange Commission (the 'SEC'). About Superior Industries Superior is one of the world's leading aluminum wheel suppliers. Superior's team collaborates with customers to design, engineer, and manufacture a wide variety of innovative and high-quality products utilizing the latest light weighting and finishing technologies. Superior serves the European aftermarket with the brands ATS®, RIAL®, ALUTEC®, and ANZIO®. Headquartered in Southfield, Michigan, Superior is listed on the New York Stock Exchange. For more information, please visit Forward-Looking Statements This press release contains statements that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can generally be identified by the use of future dates or words such as 'assumes,' 'may,' 'should,' 'could,' 'will,' 'expects,' 'expected,' 'seeks to,' 'anticipates,' 'plans,' 'believes,' 'estimates,' 'foresee,' 'intends,' 'guidance,' 'predicts,' 'projects,' 'projecting,' 'potential,' 'targeting,' 'will likely result,' or 'continue,' or the negative of such terms and other comparable terminology. These forward-looking statements involve a number of risks and uncertainties, some of which are beyond Superior's control, including, without limitation, future fluctuations in the Company's market capitalization and stockholders' equity; its ability to regain compliance with the Manual and maintain a listing of the Common Stock on NYSE. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, risks, and uncertainties discussed in Superior's SEC filings and reports. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Superior. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law.
1News
5 days ago
- Politics
- 1News
Seymour defends posts accusing opponents of 'derangement syndrome'
The Deputy Prime Minister is rubbishing claims that social media posts he has made about opponents of the Regulatory Standards Bill are a breach of the Cabinet Manual. In recent days, David Seymour made a series of social media posts singling out prominent opponents of the Bill, and accusing them of suffering from "Regulatory Standards Derangement Syndrome". Wellington's mayor, Tory Whanau, accused Seymour of setting a "dangerous precedent" for how dissenting voices were treated, and laid a formal complaint with the Prime Minister over the posts. The Regulatory Standards Bill aimed to ensure regulatory decisions were "based on principles of good law-making and economic efficiency", according to Seymour, who had introduced the Bill as Minister of Regulation. Opponents criticised it as advancing corporate interests and an attack on nature and Te Tiriti. ADVERTISEMENT Seymour's targets included academics such as Dame Anne Salmond, Dr George Laking, and Metiria Turei, as well as Labour MP Willie Jackson. Dame Anne Salmond was referred to as the "victim of the day" by Seymour. (Source: Newsroom published an opinion column by Dame Anne, in which she called the bill a "dangerous piece of legislation" and said its principles were "largely inspired by libertarian ideals". In the posts, Seymour called the figures the "Victim of the Day" and set out why he believed their arguments against the Bill were wrong. In Dame Anne's case, Seymour said her "real objection seems to be that the Bill sets limits on arbitrary power". "That it dares to elevate individual rights, due process, and cost-benefit analysis over ideology. That's not a weakness, it's the point." He said Turei was "spinning conspiracies" and that Jackson had a "wild imagination". ADVERTISEMENT The posts prompted Whanau to write to the Prime Minister, accusing Seymour of orchestrating a "campaign of online harassment and intimidation." Whanau's letter said the posts were a "blatant attempt to stifle academic opinion and any dissenting opinion", and a breach of Sections 2.53 and 2.56 of the Cabinet Manual. Wellington Mayor Tory Whanau. (Source: 1News) Section 2.53 called on ministers to "conduct themselves in a manner appropriate to the office", while Section 2.56 said ministers were expected to behave in a way that upheld the highest ethical and behavioural standards. "This includes exercising a professional approach and good judgement in their interactions with the public, staff, and officials, and in all their communications, personal and professional," it says. Whanau, who at this stage has not been the subject of one of Seymour's posts, called on Christopher Luxon to investigate the matter. "For the Deputy Prime Minister to lead this online harassment campaign is quite concerning, as such actions could incite behaviour that spills into real-world violence. ADVERTISEMENT "This is irresponsible and a clear breach of public trust. We expect our leaders to keep us safe, not throw us into harm's way," she wrote. On Monday, standing in for Luxon at the post-Cabinet press conference, Seymour dismissed the criticism and accused the opponents of the bill of making incorrect statements. "There's no such breach. If people want to go out and make completely incorrect statements, then I'm going to get a bit playful and have some fun with them." He argued that pointing out there was a "curious syndrome that is causing people to say untrue things" was different to outright calling them deranged. "I could say that their incorrect statements are deliberate, and therefore they're lying. I could say they're incapable of understanding what they're saying. "I'm not saying that, I'm being a bit playful saying the only reason I can think of for all these totally factually incorrect statements about the Regulatory Standards Bill is that there's some sort of sinister syndrome out there." Labour leader Chris Hipkins said Seymour's behaviour was "inconsistent" with what was expected of MPs, particularly Ministers of the Crown. ADVERTISEMENT Labour leader Chris Hipkins. (Source: "When you're putting photos of people up with the derogatory sorts of claims that David Seymour is, that is online harassment and I don't think it's acceptable," he said. Hipkins said singling out members of the public was different to the cut and thrust of political debate between politicians. "Attacking other politicians is one thing. Attacking members of the public is something entirely different." In a follow-up column, also on Newsroom, Dame Anne said Seymour's campaign was "lame, even laughable" but also an abuse of high office, and she would formally lodge a complaint with the Cabinet Office. The Regulatory Standards Bill passed its first reading in May. Submissions on the Bill closed on Monday. ADVERTISEMENT The Finance and Expenditure Committee will consider the submissions, with its final report due by November 22nd. Labour has pledged to repeal the Regulatory Standards Bill in its first 100 days in office, should it return to government next year.
Hindustan Times
20-06-2025
- Health
- Hindustan Times
Nephrologists bust 7 common myths about kidney disease: Is it actually preventable to is dialysis inevitable
According to the US-based National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), chronic kidney disease means that the kidneys are damaged and can't filter blood as they should. In an interview with HT Lifestyle, Dr Saiprasad Sahoo, senior consultant – nephrology, Manipal Hospital Bhubaneswar, shared that when it comes to maintaining kidney health, there are several myths that prevent people from taking the right steps to protect their kidneys. Also read | Do you overuse paracetamol? Urologist says it can increase kidney cancer risk; know these 10 everyday habits to avoid Dr Sahoo said, 'Kidneys are the silent warriors of the body – they filter waste, regulate electrolyte balance and blood pressure (BP), and keep us healthy. However, kidneys are susceptible to damage from various factors like poor diet, lifestyle habits, and underlying health conditions. Apart from lifestyle factors, kidney disease is also aggravated by known risk factors like diabetes and high blood pressure.' He added that to maintain kidney health, make conscious dietary choices and healthy lifestyle habits: 'Track your health parameters, eat good food, stay hydrated, avoid smoking, and manage your stress to ensure that your kidneys remain functional for a long time.' According to Dr Maria Bethsaida Manual, consultant, nephrology, and transplant physician, Manipal Hospital Whitefield, there are several myths surrounding kidney disease that 'lead to confusion, and delayed diagnosis and treatment'. Dr Sahoo and Dr Manual shared a bunch of myths they wish you would stop believing: 1. 'One such myth is that only the elderly are at risk of kidney disease. In reality, kidney issues can affect people of all ages, especially those with diabetes, high BP, or a family history of kidney issues,' Dr Sahoo said. 2. Does drinking water prevent kidney disease? According to Dr Manual: 'Staying hydrated is important to kidney health, but in some kidney diseases, such as End-Stage Renal Disease or Chronic Kidney Disease Stage 5, overhydration can be harmful.' 3. Dr Manual said that people think no symptoms mean the kidneys are fine. 'Kidney disease progresses silently, which means there are no symptoms until significant damage has already occurred,' she said. 4. 'Another popular belief is that herbal products can cure kidney disease. However, many herbal remedies contain unregulated and toxic substances that may be harmful to the kidneys. Therefore, please visit your doctor before using them exclusively,' Dr Sahoo said. 5. He added, 'Many people think that painkillers are harmless. But not many realise that overuse of non-steroidal anti-inflammatory drugs (NSAIDs) can damage the kidneys in people with existing risk factors.' 6. Another myth is that dialysis is inevitable if you have kidney disease. However, according to Dr Manual, 'Not all patients progress to ESRD (End-Stage Renal Disease). Many patients can maintain stable kidney function for years with proper lifestyle and medical treatment.' 7. Many also think that kidney disease is not preventable. Reacting to which, Dr Manual said, 'While not all forms are preventable, healthy lifestyle changes like controlling BP, blood glucose, and staying active gradually reduce the risk of disease progression.' Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Business Wire
05-06-2025
- Business
- Business Wire
Superior Industries International, Inc. Receives NYSE Continued Listing Standards Notice
SOUTHFIELD, Mich.--(BUSINESS WIRE)-- Superior Industries International, Inc. ('Superior' or the 'Company') (NYSE:SUP), one of the world's leading aluminum wheel suppliers, today announced that on June 2, 2025, it received written notice (the 'Notice') from the New York Stock Exchange ('NYSE') of non-compliance with Section 802.01B of NYSE Listed Company Manual (the 'Manual'), which requires an average global market capitalization of not less than $50 million over a consecutive 30-trading day period and stockholders' equity of not less than $50 million. As set forth in the Notice, as of May 30, 2025, the Company's 30-trading day average market capitalization was approximately $45.9 million, and the Company's last reported stockholders' deficit, as of March 31, 2025, was approximately $(288.7) million. In accordance with applicable NYSE procedures, within 45 days from receipt of the Notice, the Company must submit to NYSE a business plan that demonstrates compliance with Section 802.01B of the Manual within 18 months of receipt of the Notice. The Listing Operations Committee of NYSE will review the business plan and will either accept the plan, at which time the Company will be subject to ongoing quarterly monitoring for compliance with the business plan, or reject it, at which time the Company will be subject to suspension and delisting proceedings. The Company expects to timely submit such a business plan to NYSE. Pursuant to NYSE rules, the Company's common stock will continue to be listed and traded on NYSE during the cure periods outlined above, subject to the Company's compliance with other NYSE continued listing requirements. The current noncompliance with the standards described above does not affect the Company's ongoing business operations or its reporting requirements with the Securities and Exchange Commission (the 'SEC'). About Superior Industries Superior is one of the world's leading aluminum wheel suppliers. Superior's team collaborates with customers to design, engineer, and manufacture a wide variety of innovative and high-quality products utilizing the latest light weighting and finishing technologies. Superior serves the European aftermarket with the brands ATS®, RIAL®, ALUTEC®, and ANZIO®. Headquartered in Southfield, Michigan, Superior is listed on the New York Stock Exchange. For more information, please visit Forward-Looking Statements This press release contains statements that are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can generally be identified by the use of future dates or words such as 'assumes,' 'may,' 'should,' 'could,' 'will,' 'expects,' 'expected,' 'seeks to,' 'anticipates,' 'plans,' 'believes,' 'estimates,' 'foresee,' 'intends,' 'guidance,' 'predicts,' 'projects,' 'projecting,' 'potential,' 'targeting,' 'will likely result,' or 'continue,' or the negative of such terms and other comparable terminology. These forward-looking statements involve a number of risks and uncertainties, some of which are beyond Superior's control, including, without limitation, future fluctuations in the Company's market capitalization and stockholders' equity; its ability to submit a required business plan and regain compliance with the Manual and maintain a listing of the Company's common stock on NYSE. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, risks, and uncertainties discussed in Superior's SEC filings and reports. New risks and uncertainties arise from time to time, and it is impossible for us to predict these events or how they may affect Superior. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events and/or otherwise, except as may be required by law
